Evidence map›Paper›PMID 39361291›Full record

ArticleInvestigative ophthalmology & visual science2024

Longitudinal Assessment of Retinal Microvasculature in Preclinical Alzheimer's Disease.

Katie R Curro, Ruth M A van Nispen, Anouk den Braber, Elsmarieke M van de Giessen, Jacoba A van de Kreeke, H Stevie Tan, Pieter-Jelle Visser, Femke H Bouwman, Frank D Verbraak

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Cerebral Amyloid Deposition WithHuman brain mapping · 2025
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katie R CurroDepartment of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.
Ruth M A van NispenDepartment of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.
Anouk den BraberAlzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC, Amsterdam, The Netherlands.
Elsmarieke M van de GiessenDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands.
Jacoba A van de KreekeDepartment of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.
H Stevie TanDepartment of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.
Pieter-Jelle VisserAlzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC, Amsterdam, The Netherlands.
Femke H BouwmanAlzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC, Amsterdam, The Netherlands.
Frank D VerbraakDepartment of Ophthalmology, Amsterdam UMC, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate if changes in vessel density (VD) and the foveal avascular zone (FAZ) occur in the preclinical phase of Alzheimer's disease (pAD) over time. Methods: Optical coherence tomography angiography (OCTA) was used to image VD and FAZ at baseline and for a follow-up period of 2 years. Positron emission tomography (PET) was used to determine the amyloid beta (Aβ) status of participants. Results: The VD and FAZ of 148 participants (54% female) were analyzed at baseline and follow-up (mean time between measurements, 2.24 ± 0.35 years). The mean age of the participants was 68.3 ± 6.0 years at baseline and 70.3 ± 5.9 years at follow-up. Participants were divided into three groups: control group, participants who had negative Aβ status at both measurements (Aβ-, n = 116); converter group, participants who transitioned from negative to positive between baseline and follow-up (Aβ-+, n = 18); and participants who were consistently positive at both visits (Aβ++, n = 14). The VD of both Aβ+ groups demonstrated non-significant increases over time in both macula and optic nerve head (ONH) regions. The Aβ- group was found to be significantly higher in both ONH and macular regions. The VD of the Aβ++ group was significantly higher in the macula inner and outer rings compared to the Aβ-+ and Aβ- groups. No significant change was found in FAZ values over time. Conclusions: Alterations in VD seem to manifest already in pAD, exhibiting distinct variations between the ONH and macula. Further longitudinal studies with a longer follow-up design and known amyloid pathology should be undertaken to validate these observations.

Indexed as

Alzheimer DiseaseFluorescein AngiographyRetinal VesselsTomography, Optical CoherenceAgedAmyloid beta-PeptidesDisease ProgressionFemaleFollow-Up StudiesFovea CentralisHumansMaleMicrovesselsMiddle AgedPositron-Emission TomographyAmyloid beta-Peptides

Identifiers

PMID39361291
PMCPMC11451830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.